Tag Archives: PTN

Friday’s Midday Movers: American Green Inc (ERBB), Halcon Resources (HK), Can-Fite BioPharma (CANF), Palatin Technologies (PTN), Achillion Pharmaceuticals (ACHN)

So far Friday, May 17, NASDAQ is up 1.19% and the S&P is up 2.61%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; American Green Inc (ERBB – Research Report), Halcon Resources (HK

Friday’s Highlights at Noon: Halcon Resources (HK), Can-Fite BioPharma (CANF), Palatin Technologies (PTN), Achillion Pharmaceuticals (ACHN), Curis Inc (CRIS)

So far Friday, May 17, NASDAQ is up 1.19% and the S&P is up 2.68%. Here are this morning’s most active stocks: Halcon Resources (HK – Research Report), Can-Fite BioPharma (CANF – Research Report), Palatin Technologies (PTN – Research Report),

Ladenburg Believes Palatin Technologies (NYSE MKT: PTN) Won’t Stop Here

In a report issued on May 10, Michael Higgins from Ladenburg maintained a Buy rating on Palatin Technologies (PTN – Research Report), with a price target of $2.75. The company’s shares closed on Friday at $1.42, close to its 52-week

Palatin Technologies (PTN) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Palatin Technologies (PTN – Research Report) today and set a price target of $5. The company’s shares closed yesterday at $0.75, close to its 52-week low of $0.59. Pantginis said:

A Director at Palatin Technologies (NYSE: PTN) is Buying Shares

Today, a Director at Palatin Technologies (PTN – Research Report), Alan Dunton, bought shares of PTN for $8,005. This is Dunton’s first transaction since reporting a Sell transaction on OGEN back in March 2014 Following this transaction Alan Dunton’s holding

Thursday’s Midday Movers: Palatin Technologies (PTN), Anthera Pharmaceuticals (ANTH), Curis Inc (CRIS), SeaDrill LTD (SDRL), Cytosorbents Corp (CTSO)

So far Thursday, May 24, NASDAQ is down -0.52% and the S&P is down -0.04%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Palatin Technologies (AMEX:PTN), Anthera Pharmaceuticals (NASDAQ:ANTH), Curis Inc (NASDAQ:CRIS), SeaDrill